Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyumjev in Adult Patients With Type 2 Diabetes Mellitus in India
NCT06370715Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2024
- Primary completion
- Sep 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin lispro-aabc in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Apr 2024; status: completed.
02
Drugs
insulin lispro-aabc
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06370715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06370715.